+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 159 Pages
  • October 2024
  • Region: Global
  • GlobalData
  • ID: 6025448
The Medical Devices sector report, “Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Colorectal Cancer Screening Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Colorectal cancer screening tests are carried to monitor bowel health of at-risk individuals, typically the elderly, in order to be able to detect and treat colorectal cancer in a timely manner.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Colorectal Cancer Screening Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Screening Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Screening Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Colorectal Cancer Screening Tests Overview
3 Products under Development
3.1 Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
3.2 Colorectal Cancer Screening Tests - Pipeline Products by Segment
3.3 Colorectal Cancer Screening Tests - Pipeline Products by Territory
3.4 Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
3.5 Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
3.6 Colorectal Cancer Screening Tests - Ongoing Clinical Trials
4 Colorectal Cancer Screening Tests - Pipeline Products under Development by Companies
4.1 Colorectal Cancer Screening Tests Companies - Pipeline Products by Stage of Development
4.2 Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
5 Colorectal Cancer Screening Tests Companies and Product Overview6 Colorectal Cancer Screening Tests- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • Colorectal Cancer Screening Tests - Pipeline Products by Segment
  • Colorectal Cancer Screening Tests - Pipeline Products by Territory
  • Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
  • Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
  • Colorectal Cancer Screening Tests - Ongoing Clinical Trials
  • Colorectal Cancer Screening Tests Companies - Pipeline Products by Stage of Development
  • Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • Acuamark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • CRC Recurrence Panel - Product Status
  • CRC Recurrence Panel - Product Description
  • Eagle i5 - Product Status
  • Eagle i5 - Product Description
  • Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
  • PreveCol - Product Status
  • PreveCol - Product Description
  • Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Cchek - Colon Cancer Screening Test - Product Status
  • Cchek - Colon Cancer Screening Test - Product Description
  • Arbele Corp Pipeline Products & Ongoing Clinical Trials Overview
  • CDH17 - Blood Test - Product Status
  • CDH17 - Blood Test - Product Description
  • Augusta University Pipeline Products & Ongoing Clinical Trials Overview
  • Folate Receptor Biomarker Test - Cervical Cancer - Product Status
  • Folate Receptor Biomarker Test - Cervical Cancer - Product Description
  • Bar Harbor BioTechnology Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Genetic Diagnostic Test - Colorectal Cancer - Product Status
  • Genetic Diagnostic Test - Colorectal Cancer - Product Description
  • Beacon Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • ColoRT - Product Status
  • ColoRT - Product Description
  • Beckman Research Institute Of The City Of Hope Pipeline Products & Ongoing Clinical Trials Overview
  • Biomarker Test - Colorectal Cancer - Product Status
  • Biomarker Test - Colorectal Cancer - Product Description
  • Beijing Youxun Medical Laboratory Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Youxu Colorectal Cancer IVD Test - Product Status
  • Youxu Colorectal Cancer IVD Test - Product Description
  • BGI Genomics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • COLOTECT 3.0 - Product Status
  • COLOTECT 3.0 - Product Description
  • Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview
  • OncoCEE - CR (FISH) - Product Status
  • OncoCEE - CR (FISH) - Product Description
  • Biome Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • BiomeCRC - Product Status
  • BiomeCRC - Product Description
  • Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • DecisionDx - Rectal Cancer - Product Status
  • DecisionDx - Rectal Cancer - Product Description
  • CellMax Life Inc Pipeline Products & Ongoing Clinical Trials Overview
  • FirstSight Blood Test - Colorectal Cancer - Product Status
  • FirstSight Blood Test - Colorectal Cancer - Product Description
  • Celtic Medical BV Pipeline Products & Ongoing Clinical Trials Overview
  • Celtic Panel - Colorectal Cancer - Product Status
  • Celtic Panel - Colorectal Cancer - Product Description
  • CRC Bioscreen Pipeline Products & Ongoing Clinical Trials Overview
  • Immunochemical Test - Colorectal Cancer - Product Status
  • Immunochemical Test - Colorectal Cancer - Product Description
  • Creative Biosciences (Guangzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Colosafe 2.0 - Product Status
  • Colosafe 2.0 - Product Description
  • Curo Biosciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • ERLYSIGN Kit - Colorectal Cancer - Product Status
  • ERLYSIGN Kit - Colorectal Cancer - Product Description
  • Diagen Pipeline Products & Ongoing Clinical Trials Overview
  • Colon Cancer Diagnostic Kit - Product Status
  • Colon Cancer Diagnostic Kit - Product Description
  • DiagNodus Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Diagnostic Test - Colorectal Cancer - Product Status
  • Diagnostic Test - Colorectal Cancer - Product Description
  • EHang (Suzhou) Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Blood-Based Exosome Assay - Colorectal Cancer - Product Status
  • Blood-Based Exosome Assay - Colorectal Cancer - Product Description
  • Epigenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Next-Generation Colorectal Cancer Test - Product Status
  • Next-Generation Colorectal Cancer Test - Product Description
  • Epigenomics Inc - Ongoing Clinical Trials Overview
  • Next-Generation Colorectal Cancer Test - Prospective, Multi-center Observational Study for the Clinical Validation of the Next Generation Test for Blood-based Screening of Colorectal Cancer
  • Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Circulating Tumor DNA Test - Colorectal Cancer - Product Status
  • Circulating Tumor DNA Test - Colorectal Cancer - Product Description
  • Exact Sciences Corp - Ongoing Clinical Trials Overview
  • Circulating Tumor DNA Test - Colorectal Cancer - CORRECT-MRD I: First Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
  • Circulating Tumor DNA Test - Colorectal Cancer - CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
  • Faknostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • FAKnosTest CRC Prognostic - Product Status
  • FAKnosTest CRC Prognostic - Product Description
  • Foundation Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
  • ctDNA Monitoring Assay - Product Status
  • ctDNA Monitoring Assay - Product Description
  • G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview
  • Colon Cancer-Screening Test - Product Status
  • Colon Cancer-Screening Test - Product Description
  • Geneoscopy LLC Pipeline Products & Ongoing Clinical Trials Overview
  • ColoSense - Product Status
  • ColoSense - Product Description
  • Genetic Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Genetic Test - Colorectal Cancer - Product Status
  • Genetic Test - Colorectal Cancer - Product Description
  • Genetron Health (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • CRC Early Screening Assay - Product Status
  • CRC Early Screening Assay - Product Description
  • Genoptix Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Epidermal Growth Factor Receptor Assay - Colon Cancer - Product Status
  • Epidermal Growth Factor Receptor Assay - Colon Cancer - Product Description
  • Guardant Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Guardant360 Liquid Biopsy Test - Product Status
  • Guardant360 Liquid Biopsy Test - Product Description
  • LUNAR-2 Assay - Product Status
  • LUNAR-2 Assay - Product Description
  • Guardant Health Inc - Ongoing Clinical Trials Overview
  • LUNAR-2 Assay - Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
  • Hangzhou Heyi Gene Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Fecal DNA Test - Colorectal Cancer - Product Status
  • Fecal DNA Test - Colorectal Cancer - Product Description
  • Human Metabolome Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Biomarker Based Assay - Colorectal Cancer - Product Status
  • Biomarker Based Assay - Colorectal Cancer - Product Description
  • iCellate Medical AB Pipeline Products & Ongoing Clinical Trials Overview
  • CellMate - Colorectal Cancer - Product Status
  • CellMate - Colorectal Cancer - Product Description
  • Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • PathFinderTG - Colon (Supernatant) - Product Status
  • PathFinderTG - Colon (Supernatant) - Product Description
  • JL Medi Labs Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Diagnostic Test - Colorectal Cancer - Product Status
  • Diagnostic Test - Colorectal Cancer - Product Description
  • Mainz Biomed NV Pipeline Products & Ongoing Clinical Trials Overview
  • Next Generation AA/CRC Screening Test - Product Status
  • Next Generation AA/CRC Screening Test - Product Description
  • Mainz Biomed NV - Ongoing Clinical Trials Overview
  • Next Generation AA/CRC Screening Test - Clinical Performance of the Mainz Biomed Colorectal Cancer Screening Test for the Detection of Colorectal Cancer and Advanced Adenoma in an Average Risk Population
  • Next Generation AA/CRC Screening Test - Validity and Diagnostic Performance of an Optimized Multi-target Stool Nucleic Acid Test Combined with FIT (Mainz Biomed Colorectal Cancer Screening Test) for Early Detection of Colorectal Cancer and Advanced Precancerous Lesions in Colon
  • mBioSys Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Detection Kit - Colorectal Cancer - Product Status
  • Detection Kit - Colorectal Cancer - Product Description
  • Neuome Peptides Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Diagnostic Assay - Colorectal Cancer - Product Status
  • Diagnostic Assay - Colorectal Cancer - Product Description
  • New Day Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • ColoHealth - Product Status
  • ColoHealth - Product Description
  • Nucleix Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Colon EpiCheck - Product Status
  • Colon EpiCheck - Product Description
  • Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
  • Multiplexed Paper-Based Blood Test - Colorectal Cancer - Product Status
  • Multiplexed Paper-Based Blood Test - Colorectal Cancer - Product Description
  • Oncodiag Pipeline Products & Ongoing Clinical Trials Overview
  • Colodiag - Product Status
  • Colodiag - Product Description
  • Oncomark Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • OncoMasTR - Colorectal Cancer - Product Status
  • OncoMasTR - Colorectal Cancer - Product Description
  • Ourotech Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Organ-On-A-Chip Device - Colorectal Cancer - Product Status
  • Organ-On-A-Chip Device - Colorectal Cancer - Product Description
  • Prenetics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • ColoClear - Product Status
  • ColoClear - Product Description
  • Prenetics Ltd - Ongoing Clinical Trials Overview
  • ColoClear - Multi-omics Study for Early Detection of Colorectal Cancer Based on Liquid Biopsy Technology (MOED-CRC)
  • Preora Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Cancer Risk Stratification Test - Colorectal Cancer - Product Status
  • Cancer Risk Stratification Test - Colorectal Cancer - Product Description
  • QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Q-POC - HPV Assay - Product Status
  • Q-POC - HPV Assay - Product Description
  • Rarity Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview
  • Colorectal Cancer Panel - Product Status
  • Colorectal Cancer Panel - Product Description
  • Rhythm Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • ColoSTAT - Product Status
  • ColoSTAT - Product Description
  • Shanghai Singlera Genomics Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • ColonAiQ - Product Status
  • ColonAiQ - Product Description
  • Shenzhen Youshengkang Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Blood Test - Colorectal Cancer - Product Status
  • Blood Test - Colorectal Cancer - Product Description
  • Singlera Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • ColonES Assay - Product Status
  • ColonES Assay - Product Description
  • Surfix BV Pipeline Products & Ongoing Clinical Trials Overview
  • MultitargetFIT Test - Product Status
  • MultitargetFIT Test - Product Description
  • The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
  • Colorectal Cancer Screening Tool - Product Status
  • Colorectal Cancer Screening Tool - Product Description
  • Fecal Test - Colorectal Cancer - Product Status
  • Fecal Test - Colorectal Cancer - Product Description
  • Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Diagnostic Test - Colorectal Cancer - Product Status
  • Diagnostic Test - Colorectal Cancer - Product Description
  • University of Helsinki Pipeline Products & Ongoing Clinical Trials Overview
  • Polygenic Risk Score Test - Colorectal Cancer - Product Status
  • Polygenic Risk Score Test - Colorectal Cancer - Product Description
  • University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • Companion Diagnostic Assay - Colorectal Cancer - Product Status
  • Companion Diagnostic Assay - Colorectal Cancer - Product Description
  • Vastcon Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Screening Test - Colorectal Cancer - Product Status
  • Screening Test - Colorectal Cancer - Product Description
  • VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Nu.Q CRC Screening Test - Product Status
  • Nu.Q CRC Screening Test - Product Description
  • Nu.Q CRC Symptomatic Test - Product Status
  • Nu.Q CRC Symptomatic Test - Product Description
  • Nu.Q Frontline Asymptomatic CRC Screening Test - Product Status
  • Nu.Q Frontline Asymptomatic CRC Screening Test - Product Description
  • VolitionRX Ltd - Ongoing Clinical Trials Overview
  • Nu.Q CRC Screening Test - Prospective Clinical Study Nu.Q Assay for the Detection of Colorectal Cancer
  • Zhongjing Pukang (Beijing) Pharmaceutical Technology Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Screening Device - Colorectal Cancer - Product Status
  • Screening Device - Colorectal Cancer - Product Description
  • Glossary
List of Figures
  • Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • Colorectal Cancer Screening Tests - Pipeline Products by Segment
  • Colorectal Cancer Screening Tests - Pipeline Products by Territory
  • Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
  • Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
  • Colorectal Cancer Screening Tests - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Acuamark Diagnostics Inc
  • Advanced Marker Discovery SL
  • Anixa Diagnostics Corporation
  • Arbele Corp
  • Augusta University
  • Bar Harbor BioTechnology Inc (Inactive)
  • Beacon Biomedical Inc
  • Beckman Research Institute Of The City Of Hope
  • Beijing Youxun Medical Laboratory Co Ltd
  • BGI Genomics Co Ltd
  • Biocept Inc
  • Biome Diagnostics GmbH
  • Castle Biosciences Inc
  • CellMax Life Inc
  • Celtic Medical BV
  • CRC Bioscreen
  • Creative Biosciences (Guangzhou) Co Ltd
  • Curo Biosciences Pvt Ltd
  • Diagen
  • DiagNodus Ltd
  • EHang (Suzhou) Biomedical Co Ltd
  • Epigenomics Inc
  • Exact Sciences Corp
  • Faknostics LLC
  • Foundation Medicine Inc
  • G Medical Health and Wellness
  • Geneoscopy LLC
  • Genetic Technologies Ltd
  • Genetron Health (Beijing) Co Ltd
  • Genoptix Inc (Inactive)
  • Guardant Health Inc
  • Hangzhou Heyi Gene Technology Co Ltd
  • Human Metabolome Technologies Inc
  • iCellate Medical AB
  • Interpace Biosciences Inc
  • JL Medi Labs Co Ltd
  • Mainz Biomed NV
  • mBioSys Pvt Ltd
  • Neuome Peptides Pte Ltd
  • New Day Diagnostics LLC
  • Nucleix Ltd
  • Ohio State University
  • Oncodiag
  • Oncomark Ltd
  • Ourotech Ltd
  • Prenetics Ltd
  • Preora Healthcare Inc
  • QuantuMDx Group Ltd
  • Rarity Bioscience AB
  • Rhythm Biosciences Ltd
  • Shanghai Singlera Genomics Technologies Co Ltd
  • Shenzhen Youshengkang Biotechnology Co., Ltd.
  • Singlera Genomics Inc
  • Surfix BV
  • The Chinese University of Hong Kong
  • Thermo Fisher Scientific Inc
  • University of Helsinki
  • University of Oxford
  • Vastcon Inc
  • VolitionRX Ltd
  • Zhongjing Pukang (Beijing) Pharmaceutical Technology Co., Ltd